Patterns, pearls and practical medicine

NSTEMI

  • A Non-ST elevation MI is defined as
      • Elevated biomarkers
          • Dynamic troponin (ie significant change), with at least one elevated value (>99th centile). Exact numbers depend on assay.
      • And evidence of myocardial ischaemia
          • ECG suggestive
              • New horizontal or downsloping ST depression of >0.5mm in 2 contiguous leads or
              • Dynamic T wave changes in 2 contiguous leads
          • Or ischaemic sounding chest pain
          • Or imaging suggestive of new ischaemia
  • The ECG
      • ST depression of >1mm is more specific and worse prognostically
      • Upsloping ST depression is non-specific for myocardial ischaemia (often seen in tachyarrhymias)
      • The ST depression and TWI of NSTEMI are less clearly related to the site of myocardial damage than in STEMI
      • ECG may be normal in 30%

Assessing risk

  • Do the GRACE score
      • Gives in-hospital and 6-month risk of mortality in NSTEMI
      • 5-3% is low, 3-6% is intermediate, 6-9% is high, >9% is highest
  • Assess for high risk features (urgent PCI may be indicated if present)
    • TWI V1-V4 ie LAD syndrome
    • Trop+++
    • Unstable patient
    • Arrhythmia
    • Shock
    • Ongoing chest pain (ie. patient currently infarcting)

Management strategy

  • 300mg loading aspirin, and then continue at 75mg OD
  • GTN spray if pain ongoing
  • Anticoagulation
      • Fondaparinux 2.5mg OD
          • Used if no high bleeding risk, and not undergoing angiography in the next 24 hours
          • Mainly used in NSTEMI whilst awaiting angiography (not used in STEMI patients a/w PCI)
      • Unfractionated heparin
          • Alternative to fondaparinux if creat >265
          • Also give in cath lab if having PCI (whether or not received fondaparinux)
          • Also indicated in NSTEMI if anticipating early PCI (ie in next 24 hours) – start at time of MI diagnosis
      • Consider contraindications
          • Absolute: anticoagulated, severe renal impairment, active bleeding, recent intracranial haemorrhage, major surgery in last 2 months, IE
          • Relative: bleeding disorder, severe HTN, severe liver failure, CVA in last 2 years, low platelets, low BMI
      • Usually stop anticoagulants after PCI (except if LV aneurysm with thrombus, or AF)
  • Consider a second antiplatelet
      • Depends on trust policy and how long until angiogram – any delay, probably give DAPT (if bleeding risk not high), but guidelines suggest not giving if PCI planned within 24 hours
      • If having PCI, offer aspirin with prasugrel or ticagrelor (if not anticoagulated) at the time of PCI
      • If not having PCI, offer aspirin and ticagrelor (unless high bleeding risk – in which case consider clopidogrel)
      • No renal dose adjustments required unless eGFR <15 (then probably need heparin infusion)
      • Options – see Acute Coronary Syndrome
  • GTN infusion – if ongoing pain (50mg in 50ml saline, run at 2-10ml/hour)
  • Betablocker
      • Often commenced unless contraindicated – best is metoprolol 25mg
      • Not in acute heart failure, asthma, hypotension, bradycardia
      • Reduces myocardial O2 demand
      • If contraindicated, consider diltiazem, but avoid nifedipine / other CCBs

  • Percutaneous Coronary Intervention (PCI)
      • Emergency PCI (treat as STEMI) if high risk features (see above) or patient unstable (or consider emergency CABG)
      • If out of hospital arrest, ROSC and stable – best to delay PCI and exclude non-cardiac causes
      • Consider PCI within 72 hours if intermediate or high risk on GRACE score (6/12 risk >3%) and no contraindications to angiography (eg active bleeding, a comorbidity)
      • Consider PCI within 24 hours if GRACE score > 140
      • Consider PCI if low risk on GRACE if ischaemia subsequently experienced or demonstrated by testing, esp if younger (who have lower expected mortality)
      • Benefits of PCI include – reduced mortality from all causes at 6, 12 and 24 months. Reduced incidence of MI and stroke. Reduces risk of readmission
      • Risks include – procedural (incl major bleeding and MI)

  • Later
        • Consider early discharge if aged <70, good LV function, successful PCI, one or two vessel disease and no persistent arrythmias
        • Bystander disease – make a plan whether to treat later if present (and as inpatient or outpatient)
        • Consider ischaemia-testing before discharge if no angiogram done
        • Echo
            • Usually non-urgent but done during same admission
            • If LV function <40%, repeat in 6-12 weeks
        • Lifestyle advice – diet, exercise, weight, smoking, ETOH

 

Scroll to Top

Comments and corrections

Help us improve by reporting your comments and corrections.

Thank you!

Your comment has been sent. We review all submissions carefully.